Emily Harris

1.2k total citations · 1 hit paper
60 papers, 852 citations indexed

About

Emily Harris is a scholar working on Pharmacology, Infectious Diseases and Surgery. According to data from OpenAlex, Emily Harris has authored 60 papers receiving a total of 852 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pharmacology, 7 papers in Infectious Diseases and 7 papers in Surgery. Recurrent topics in Emily Harris's work include COVID-19 Clinical Research Studies (3 papers), Musculoskeletal pain and rehabilitation (3 papers) and Diabetes and associated disorders (3 papers). Emily Harris is often cited by papers focused on COVID-19 Clinical Research Studies (3 papers), Musculoskeletal pain and rehabilitation (3 papers) and Diabetes and associated disorders (3 papers). Emily Harris collaborates with scholars based in United States, United Kingdom and France. Emily Harris's co-authors include Sonnenblick Eh, Yan Ma, Mark R. Lundquist, Diana G. Wang, Andrea Sboner, Cindy Hodakoski, Chantal Pauli, Rohan Bareja, Lewis C. Cantley and Xing Du and has published in prestigious journals such as Nature, JAMA and Blood.

In The Last Decade

Emily Harris

45 papers receiving 830 citations

Hit Papers

Suppression of insulin fe... 2018 2026 2020 2023 2018 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Suppression of insulin feedback enhances the efficacy of PI3K inhibitors
    2018 481 citations Emily Harris et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Emily Harris United States 10 433 192 164 131 124 60 852
Vidar Beisvåg Norway 17 371 0.9× 120 0.6× 71 0.4× 91 0.7× 78 0.6× 38 757
Nobuhide Hayashi Japan 12 423 1.0× 144 0.8× 77 0.5× 56 0.4× 127 1.0× 42 1.0k
Naifeng Liu China 18 377 0.9× 157 0.8× 92 0.6× 113 0.9× 41 0.3× 51 878
Anna Walaszczyk Poland 15 415 1.0× 93 0.5× 237 1.4× 56 0.4× 127 1.0× 31 833
Yu-Juei Hsu Taiwan 12 363 0.8× 185 1.0× 102 0.6× 193 1.5× 77 0.6× 20 864
Nhat‐Tu Le United States 16 480 1.1× 114 0.6× 71 0.4× 70 0.5× 135 1.1× 22 838
Ali N. Chamseddine France 12 287 0.7× 98 0.5× 160 1.0× 111 0.8× 246 2.0× 27 742
Trevor P. Fidler United States 16 369 0.9× 95 0.5× 118 0.7× 87 0.7× 47 0.4× 18 877

Countries citing papers authored by Emily Harris

Since Specialization
Citations

This map shows the geographic impact of Emily Harris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily Harris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily Harris more than expected).

Fields of papers citing papers by Emily Harris

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emily Harris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily Harris. The network helps show where Emily Harris may publish in the future.

Co-authorship network of co-authors of Emily Harris

This figure shows the co-authorship network connecting the top 25 collaborators of Emily Harris. A scholar is included among the top collaborators of Emily Harris based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emily Harris. Emily Harris is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Harris, Emily. (2024). Limited Pregnancy Weight Gain for People With Obesity Might Be Safe. JAMA. 331(19). 1615–1615. 1 indexed citations
2.
Harris, Emily. (2024). Microneedle Vaccine Patches Generated Immune Response in Children. JAMA. 331(23). 1982–1982.
3.
Harris, Emily. (2024). Bystander Use of Defibrillators Is Low Despite Legislation. JAMA. 331(5). 384–384.
4.
Harris, Emily. (2024). Commercial Blood Test May Identify Alzheimer Disease Brain Pathology. JAMA. 331(8). 636–636. 1 indexed citations
5.
Harris, Emily. (2024). Tirzepatide Lowered Blood Pressure in People With Obesity. JAMA. 331(10). 821–821.
6.
Harris, Emily. (2024). Perinatal Depression Tied to Higher Long-Term Risk of Death. JAMA. 331(7). 555–555. 1 indexed citations
7.
Harris, Emily. (2024). Review Calls for Standardized Long COVID Definition. JAMA. 332(2). 97–97. 2 indexed citations
8.
Harris, Emily, Carolina Donado, Matthew M. Heeney, et al.. (2023). Ketamine use for management of vaso‐occlusive pain in pediatric sickle cell disease. Pediatric Blood & Cancer. 70(5). e30254–e30254. 2 indexed citations
9.
Harris, Emily. (2023). CDC: RSV Vaccine Recommended for Older People. JAMA. 330(5). 401–401. 3 indexed citations
10.
Harris, Emily. (2023). Extended-Release Buprenorphine Receives FDA Green Light. JAMA. 329(24). 2119–2119. 1 indexed citations
11.
Harris, Emily. (2023). Research Shows Air Pollution Promotes Lung Cancer. JAMA. 329(18). 1543–1543. 4 indexed citations
12.
Harris, Emily. (2023). Two New Analyses Add to Long COVID Understanding. JAMA. 330(10). 905–905.
13.
Harris, Emily. (2023). Autoimmunity in Down Syndrome Linked to Immune System Dysregulation. JAMA. 329(12). 968–968. 2 indexed citations
14.
Donado, Carolina, Emily Harris, Matthew M. Heeney, et al.. (2023). Patient Controlled Analgesia for Vaso-Occlusive Episodes in Children: A Retrospective Study. Journal of Pain and Symptom Management. 65(5). e409–e415. 3 indexed citations
15.
Harris, Emily. (2023). Measles Outbreaks Grow Amid Declining Vaccination Rates. JAMA. 330(23). 2242–2242.
16.
Harris, Emily. (2023). Many Older People Disagree With Life Expectancy–Based Cancer Screening. JAMA. 330(17). 1612–1612. 2 indexed citations
17.
Harris, Emily. (2023). Air Pollution Tied With Increased Chance of Breast Cancer. JAMA. 330(15). 1422–1422. 1 indexed citations
18.
Harris, Emily. (2023). Federal Government Announces Long COVID Trials, Research Office. JAMA. 330(9). 797–797. 2 indexed citations
19.
Floc’h, Nicolas, Susan Ashton, Douglas Ferguson, et al.. (2019). Modeling Dose and Schedule Effects of AZD2811 Nanoparticles Targeting Aurora B Kinase for Treatment of Diffuse Large B-cell Lymphoma. Molecular Cancer Therapeutics. 18(5). 909–919. 16 indexed citations
20.
Floc’h, Nicolas, Susan Ashton, Paula Taylor, et al.. (2017). Optimizing Therapeutic Effect of Aurora B Inhibition in Acute Myeloid Leukemia with AZD2811 Nanoparticles. Molecular Cancer Therapeutics. 16(6). 1031–1040. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vidar Beisvåg Breakdown of academic impact, for papers by Nobuhide Hayashi Breakdown of academic impact, for papers by Naifeng Liu Breakdown of academic impact, for papers by Anna Walaszczyk Breakdown of academic impact, for papers by Yu-Juei Hsu Breakdown of academic impact, for papers by Nhat‐Tu Le Breakdown of academic impact, for papers by Ali N. Chamseddine Breakdown of academic impact, for papers by Trevor P. Fidler
Rankless by CCL
2026